Skip to main content

Table 1 Baseline characteristics of patients

From: Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma

Clinical Characteristics

 

Number (%)

Age (y)

Median (range)

50 (46–72)

Sex

Male

9 (100.0)

 

Female

0 (0)

Hepatitis virus

HBV infection

9 (100.0)

 

HCV infection

0 (0)

Tumour number

Median (range)

1 (1–2)

Tumour size (cm)

Median (range)

5.0 (1.3–13.2)

Tumour thrombosis

PVTT

8 (88.9)

 

IVCTT

0 (0)

Previous therapy

Surgery

1 (11.1)

 

TACE

7 (77.8)

 

RFA

2 (22.2)

 

Systemic therapy

0 (0)

  1. Abbreviations: HBV Hepatitis B virus, HCV Hepatitis C virus, PVTT Portal vein tumour thrombosis, IVCTT Inferior vena cava tumour thrombosis, TACE Transarterial chemoembolization, RFA Radiofrequency ablation